Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products

BACKGROUND: The use of pharmacokinetic (PK) studies to help design personalized prophylaxis regimens for factor VIII (FVIII) concentrate in individuals with hemophilia A has been recognized for many years but only became practical for routine clinical use with the availability of web‐accessible popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Teitel, Jerome, Sholzberg, Michelle, Iorio, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles ‐ Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938611/
https://www.ncbi.nlm.nih.gov/pubmed/33733034
http://dx.doi.org/10.1002/rth2.12476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938611/
https://www.ncbi.nlm.nih.gov/pubmed/33733034
http://dx.doi.org/10.1002/rth2.12476

Ejemplares similares